-
-
-
-
-
-
-
Acrivon Therapeutics presents preclinical data for ACR-2316 at cancer conference
-
-
-
-
-
-
-
Piper Sandler Assumes Acrivon Therapeutics Inc (ACRV) at Overweight
-
-
-
-
-
-
-
Acrivon Therapeutics (ACRV) Granted FDA Breakthrough Device Designation for ACR-368
-
-
-
-
-
-
-
H.C. Wainwright Reiterates Buy Rating on Acrivon Therapeutics Inc (ACRV)
-
-
-
-
353,174 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

